Outcomes of oral vancomycin therapy in patients with primary sclerosing cholangitis and inflammatory bowel disease

被引：0
|
作者：
Tan, D.
Demase, K.
Little, R.
Ardalan, Z.
Taylor, K.
Sparrow, M.
机构：
[1] Alfred Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
125
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [21] Associations Between Drug Exposure and Outcomes in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Fung, Brian M.
    Ali, Ahmad H.
    Tabibian, James H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (05) : 1244 - 1245
  • [22] CLINICAL AND TRANSLATIONAL OUTCOMES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE RECEIVING VEDOLIZUMAB
    Williamson, Kate D.
    Slevin, Stephanie
    Willberg, Christian
    Chapman, Roger W.
    Klenerman, Paul
    Keshav, Satish
    GASTROENTEROLOGY, 2017, 152 (05) : S1186 - S1187
  • [23] Predicting outcomes of disease in patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: a retrospective multicentric study
    Oliveira, R.
    Viegas, M., I
    Abrantes, D.
    Conde, P. Vaz
    Saraiva, M.
    Espinheira, M. D. C.
    Trindade, E.
    Carvalho, I
    Perdigoto, D.
    de Sousa, H. Tavares
    Roseira, J.
    GED, II
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i915 - i915
  • [24] Prevalence and phenotype of inflammatory bowel disease in patients with primary sclerosing cholangitis
    Huynh, D.
    Bate, J. P.
    Andrews, J. M.
    Johnson, D.
    Nind, G.
    Harley, Haj
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 48 - 48
  • [25] Endoscopic features of inflammatory bowel disease in patients with primary sclerosing cholangitis
    Smith, Timothy
    Swaroop, Prabhakar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S454 - S454
  • [26] The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
    Lynch K.D.
    Keshav S.
    Chapman R.W.
    Current Hepatology Reports, 2019, 18 (1) : 115 - 126
  • [27] Primary sclerosing cholangitis in Japanese patients: Association with inflammatory bowel disease
    Okada, H
    Mizuno, M
    Yamamoto, K
    Tsuji, T
    ACTA MEDICA OKAYAMA, 1996, 50 (05) : 227 - 235
  • [28] Prevalence and Phenotype of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis
    Huynh, Dep
    Bate, John P.
    Andrews, Jane M.
    Johnson, Richard
    LeMire, Marc
    Nind, Garry
    Harley, Hugh A.
    GASTROENTEROLOGY, 2012, 142 (05) : S991 - S991
  • [29] RACE INFLUENCES CLINICAL OUTCOMES OF PATIENTS WTIH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE
    Haj, Mona
    Bickford, Megan M.
    Forster, Erin M.
    GASTROENTEROLOGY, 2020, 158 (06) : S444 - S445
  • [30] Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis-associated inflammatory bowel disease?
    Shah, Ayesha
    Holtmann, Gerald
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (10) : 1290 - 1291
12345